4 results
10-K
2023 FY
SLRN
Acelyrin Inc
28 Mar 24
Annual report
4:21pm
our clinical trial results include, without limitation, patient baseline demographics, clinical protocol adherence, physician and patient scored outcome
8-K
EX-99.3
SLRN
Acelyrin Inc
11 Mar 24
ACELYRIN, INC. Announces Positive Top-line Results from Its Global Phase 2b/3 Clinical Trial of Izokibep in Psoriatic Arthritis
8:05am
-DI, mean (SD) Patient Demographics And Baseline Characteristics PsA Full analysis set. aMean (SD) of subpopulation (LEI0, SPARCC0, PsO-BSA ≥3 … )Stage II 22 (38.6)23 (39.0)25 (42.4)Stage III Pain NRS baseline score, mean (SD) 6.6 (1.5)6.6 (1.5)6.5 (1.6) Score ≥4 Patient Demographics
- Prev
- 1
- Next